Actively Recruiting
Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma.
Led by IRCCS San Raffaele · Updated on 2025-06-11
15
Participants Needed
1
Research Sites
430 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal non- Hodgkin lymphoma exclusively localized into the nervous system. The aim of this study is to evaluate the MRI imaging characteristics of the peritumoral area (PTA) and to correlate this information to pathological findings.
CONDITIONS
Official Title
Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients undergoing stereotactic biopsy for newly diagnosed primary central nervous system lymphomas
You will not qualify if you...
- Severe hepatic dysfunction
- Severe renal dysfunction
- Severe heart failure
- Myocardial infarction and stroke within 90 days
- Hyperreactivity against contrast agents
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS San Raffaele Scientific Institute
Milan, Milan, Italy, 20132
Actively Recruiting
Research Team
L
Laura Sincinelli
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here